
A new drug is having a dramatic effect on shrinking lung cancer tumours, according to new research.
A trial testing the drug zongertinib as a first treatment for people with advanced lung cancer who have a HER2 genetic mutation shows it can eradicate tumours in some people while reducing their size in others.